Current state and promise of user-centered design to harness explainable AI in clinical decision-support systems for patients with CNS tumors.

Journal: Frontiers in radiology
Published Date:

Abstract

In neuro-oncology, MR imaging is crucial for obtaining detailed brain images to identify neoplasms, plan treatment, guide surgical intervention, and monitor the tumor's response. Recent AI advances in neuroimaging have promising applications in neuro-oncology, including guiding clinical decisions and improving patient management. However, the lack of clarity on how AI arrives at predictions has hindered its clinical translation. Explainable AI (XAI) methods aim to improve trustworthiness and informativeness, but their success depends on considering end-users' (clinicians') specific context and preferences. User-Centered Design (UCD) prioritizes user needs in an iterative design process, involving users throughout, providing an opportunity to design XAI systems tailored to clinical neuro-oncology. This review focuses on the intersection of MR imaging interpretation for neuro-oncology patient management, explainable AI for clinical decision support, and user-centered design. We provide a resource that organizes the necessary concepts, including design and evaluation, clinical translation, user experience and efficiency enhancement, and AI for improved clinical outcomes in neuro-oncology patient management. We discuss the importance of multi-disciplinary skills and user-centered design in creating successful neuro-oncology AI systems. We also discuss how explainable AI tools, embedded in a human-centered decision-making process and different from fully automated solutions, can potentially enhance clinician performance. Following UCD principles to build trust, minimize errors and bias, and create adaptable software has the promise of meeting the needs and expectations of healthcare professionals.

Authors

  • Eric W Prince
    Department of Neurosurgery, University of Colorado School of Medicine, Aurora, CO, United States.
  • David M Mirsky
    Morgan Adams Foundation Pediatric Brain Tumor Research Program, University of Colorado School of Medicine, Aurora, CO, United States.
  • Todd C Hankinson
    Department of Neurosurgery, University of Colorado School of Medicine, Aurora, CO, United States.
  • Carsten Görg
    Department of Biostatistics & Informatics, Colorado School of Public Health, Aurora, CO, United States.

Keywords

No keywords available for this article.